POLR2B expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 7.7715611723761E-15 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.90870000307919E-08 |
Normal-vs-Stage2 |
2.203100E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.701730E-03 |
Stage1-vs-Stage2 |
5.228000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.648800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.461000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.81665793519414E-12 |
Normal-vs-AfricanAmerican |
2.309600E-01 |
Normal-vs-Asian |
1.461550E-02 |
Caucasian-vs-AfricanAmerican |
2.407600E-01 |
Caucasian-vs-Asian |
7.861000E-01 |
AfricanAmerican-vs-Asian |
4.666000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.24420000000314E-06 |
Normal-vs-Female |
3.41049966046114E-10 |
Male-vs-Female |
3.111800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.09389999999266E-05 |
Normal-vs-Extreme_Weight |
2.5593000000379E-06 |
Normal-vs-Obese |
2.974800E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
4.968800E-01 |
Normal_Weight-vs-Obese |
1.485420E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
5.042000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.161600E-01 |
Normal-vs-Age(41-60Yrs) |
5.59299999999263E-05 |
Normal-vs-Age(61-80Yrs) |
7.58070051176674E-10 |
Normal-vs-Age(81-100Yrs) |
4.808600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.716800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.101600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.576000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.605600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.068200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.881600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
1.358770E-01 |
Normal-vs-Grade 3 |
1.414200E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.334000E-01 |
Grade 2-vs-Grade 4 |
1.358770E-01 |
Grade 3-vs-Grade 4 |
1.414200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.63820134813886E-11 |
Normal-vs-N1 |
7.244700E-03 |
N0-vs-N1 |
6.113900E-02 |
|
|